Miorilax
Miorilax Brand names, Miorilax Analogs
- Alinam
- Banabil-sintyal
- Banabin
- Banabin-Sintyal
- Banabin-syntyal
- Bisina
- Chlomedinon
- Chlormethazanone
- Chlormethazone
- Chlormezanon
- Chlormezanone [BAN:INN:JAN]
- Chlormezanonum [INN-Latin]
- Clorilax
- Clormetazanone
- Clormetazon
- Clormezanona [INN-Spanish]
- Clormezanone [DCIT]
- Dichloromethazanone
- Dichloromezanone
- Fenarol
- Lobak
- Mio-Sed
- Miorilax
- Muskel
- Muskel-Trancopal
- Myolespen
- Phenarol
- Rexan
- Rilansyl
- Rilaquil
- Rilasol
- Rilassol
- Rilax
- Rillasol
- Supotran
- Suprotan
- Tanafol
- Trancopal
- Trancote
- Tranrilax
- Transanate
- dl-Chlormezanone
Miorilax Brand Names Mixture
- No information avaliable
Miorilax Chemical_Formula
C11H12ClNO3S
Miorilax RX_link
No information avaliable
Miorilax fda sheet
Miorilax msds (material safety sheet)
Miorilax Synthesis Reference
No information avaliable
Miorilax Molecular Weight
273.737 g/mol
Miorilax Melting Point
116.2 oC
Miorilax H2O Solubility
2500 mg/L (hardly soluble)
Miorilax State
Solid
Miorilax LogP
1.208
Miorilax Dosage Forms
No information avaliable
Miorilax Indication
Used in the management of anxiety and in the treatment of muscle spasm.
Miorilax Pharmacology
Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).
Miorilax Absorption
No information avaliable
Miorilax side effects and Toxicity
Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.
Miorilax Patient Information
No information avaliable
Miorilax Organisms Affected
Humans and other mammals
